INO

#4124
Inovio Pharmaceuticals, Inc.
1.13 USD
+1.80%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
1.12
1.13
年范围
1.03
2.98
日变化
+1.80%
每月变动
-32.34%
6个月变化
-56.20%
年变化
-35.80%
前一天收盘价
1.11
开盘价
1.12
买价
卖价
最低价
1.12
High
1.13
交易量
158
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 78.07 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-0.96
市销率
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

新闻